TY - JOUR T1 - Agonist-Driven Conformational Changes in the Inner β-Sheet of α7 Nicotinic Receptors JF - Molecular Pharmacology JO - Mol Pharmacol SP - 1312 LP - 1318 DO - 10.1124/mol.106.033092 VL - 71 IS - 5 AU - James T. McLaughlin AU - Jie Fu AU - Robert L. Rosenberg Y1 - 2007/05/01 UR - http://molpharm.aspetjournals.org/content/71/5/1312.abstract N2 - Cys-loop ligand-gated ion channels assemble as pentameric proteins, and each monomer contributes two structural elements: an extracellular ligand-binding domain (LBD) and a transmembrane ion channel domain. Models of receptor activation include rotational movements of subunits leading to opening of the ion channel. We tested this idea using substituted cysteine accessibility to track conformational changes in the inner β sheet of the LBD. Using a nondesensitizing chick α7 background (L247T), we constructed 18 consecutive cysteine replacement mutants (Leu36 to Ile53) and tested each for expression of acetylcholine (ACh)-evoked currents and functional sensitivity to thiol modification. We measured rates of modification in the presence and absence of ACh to identify conformational changes associated with receptor activation. Resting modification rates of eight substituted cysteines in the β1 and β2 strands and the sequence between them (loop 2) varied over several orders of magnitude, suggesting substantial differences in the accessibility or electrostatic environment of individual side chains. These differences were in general agreement with structural models of the LBD. Eight of 18 cysteine replacements displayed ACh-dependent changes in modification rates, indicating a change in the accessibility or electrostatic environment of the introduced cysteine during activation. We were surprised that the effects of agonist exposure were difficult to reconcile with rotational models of activation. Acetylcholine reduced the modification rate of M40C but increased it at N52C despite the close physical proximity of these residues. Our results suggest that models that depend strictly on rigid-body rotation of the LBD may provide an incomplete description of receptor activation. The American Society for Pharmacology and Experimental Therapeutics ER -